In patients with acute myeloid leukemia, BCL-xL overexpression was related to resistance to apoptosis, poor response to chemotherapy in addition to a poor prognosis, with leukemic infiltrations, and high white blood cell counts [40]. This evidence concerns the gene BCL2L1 and acute myeloid leukemia.